Intrauterine environment and breast cancer risk in women: A population- based study

Journal of the National Cancer Institute

Volumn 89, Issue 1, 1997, Pages 71-76

  Ekbom, Anders ^d   Hsieh, Chung Cheng ^a   Lipworth, Loren ^b   Adami, Hans Olov ^d   Trichopoulos, Dimitrios ^b,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; ESTROGEN BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN JAUNDICE; NULLIPARA; POPULATION RESEARCH; PREGNANCY TOXEMIA; RISK FACTOR;

EID: 0031037468     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.1.71     Document Type: Article

References (39)

1. Tomatis L. Overview of perinatal and multi-generation carcinogenesis. IARC Sci Publ 1989;96:1-15.
2. Hercz P, Ungar L, Siklos P, Farquharson RG. Unconjugated 17 β-oestradiol and oestriol in maternal serum and in cord vein and artery blood at term and preterm delivery. Eur J Obstet Gynecol Reprod Biol 1988;27:7-12.
3. Robboy SJ, Noller KL, O'Brien P, Kaufman RH, Townsend D, Barnes AB, et al. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 1984;252:2979-83.
4. Klopper A, Jandial V, Wilson G. Plasma steroid assay in the assessment of foetoplacental function. J Steroid Biochem 1975;6:651-6.
5. Gant NF, Hutchinson HT, Siiteri PK, MacDonald PC. Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971;111:555-63.
6. Garoff L, Seppala M, Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels. Am J Obstet Gynecol 1976;126:1027-33.
7. Long PA, Abell DA, Beischer NA. Fetal growth and placental function assessed by urinary estriol excretion before the onset of preeclampsia. Am J Obstet Gynecol 1979;135:344-7.
8. Rosing U, Carlstrom K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest 1984;18:199-205.
9. Trapp M, Kato K, Bonnet HG, Gerhard I, Weise HC, Leidenberger F. Human placental lactogen and unconjugated estriol concentrations in twin pregnancy: monitoring of fetal development in intrauterine growth retardation and single intrauterine fetal death. Am J Obstet Gynecol 1986;155:1027-31.
10. Tamby Raja RL, Ratnam SS. Plasma steroid changes in twin pregnancies. In: Gedda L, Parisi P, Nance W, editors. Twin research 3. Vol 69A. New York: Alan R Liss, 1981:189-95.
11. Duff DB, Brown JB. Urinary oestriol excretion in twin pregnancies. J Obstet Gynaecol Br Commonw 1974;81:695-700.
12. Sedin G, Bergquist C, Lindgren PG. Ovarian hyperstimulation in preterm infants. Pediatr Res 1985;19:548-52.
13. Robine N, Relier JP, Le Bars S. Urocytogram, an index of maturity in premature infants. Biol Neonate 1988;54:93-9.
14. Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR, et al. Human preterm birth is associated with systemic and local changes in progesterone/17β-estradiol ratios. Am J Obstet Gynecol 1994;171:231-6.
15. Lauritzen C, Lehmann WD. The importance of steroid hormones in the pathogenesis of hyperbilirubinemia and neonatal jaundice (German). Z Kinderheilkd 1966;95:143-54.
16. McFadyen IR, Worth HG, Wright DJ, Notta SS. High oestrogen excretion in pregnancy. Br J Obstet Gynaecol 1982;89:994-9.
17. Gerhard I, Fitzer C, Klinga K, Rahman N, Runnebaum B. Estrogen screening in evaluation of fetal outcome and infant's development. J Perinat Med 1986;14:279-91.
18. Gerhard I, Vollmar B, Runnebaum B, Klinga K, Haller U, Kubli F. Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements. Eur J Obstet Reprod Biol 1987;26:313-28.
19. Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D. Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1990;1:247-50.
20. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1990;1:119-24.
21. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986;76:1035-9.
22. Zhang Y, Cupples LA, Rosenberg L, Colton T, Kreger BE. Parental ages at birth in relation to a daughter's risk of breast cancer among female participants in the Framingham Study (United States). Cancer Causes Control 1995;6:23-9.
23. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk [see comment citations in Medline]. Lancet 1992;340:1015-8.
24. Lunde AS, Lundeborg S, Lettenstrom GS, Thugesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark and Israel. Hyattsville (MD): National Center for Health Statistics, 1980.
25. Ekbom A, Zack M, Adami HO, Helmick C. Is there clustering of inflammatory bowel disease at birth? Am J Epidemiol 1991;134:876-86.
26. The Cancer Registry. Cancer incidence in Sweden 1987. Stockholm: National Board of Health and Welfare, 1990.
27. Brown ER, Epstein M. Immediate consequences of preterm birth. In: Fuchs F, Stubblefield PG, editors. Preterm birth: causes, prevention and management. New York: Macmillan Publishing Co., 1984.
28. International Classification of Diseases, 9th revision. Clinical Modification. Baltimore (MD): HCIA, 1995:550.
29. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
30. SAS Institute. SAS technical report P-229 SAS/STAT software: changes and enhancements, release 6.07. Cary (NC): SAS Institute, 1992.
31. Anbazhagan R, Gusterson BA. Prenatal factors may influence predisposition to breast cancer. Eur J Cancer 1994;30A:1-3.
32. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E, et al. Perinatal factors and risk of breast cancer. Epidemiology 1996;7:34-7.
33. Bernstein L, Lipworth L, Ross RK, Trichopoulos D. Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 1995;142:625-8.
34. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO. Perinatal characteristics and adult mammographic patterns. Int J Cancer 1995;61: 177-80.
35. Hsieh CC, Tzonou A, Trichopoulos D. Birth order and breast cancer risk. Cancer Causes Control 1991;2:95-8.
36. Le Marchand L, Kolonel LN, Myers BC, Mi MP. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988; 57:437-9.
37. Barker DJ. Growth in utero and coronary heart disease. Nutr Rev 1996;54:(2 Pt 2):S1-7.
38. Hsieh CC, Lan SJ, Ekbom A, Petridou E, Adami HO, Trichopoulos D. Twin membership and breast cancer risk [see comment citation in Medline]. Am J Epidemiol 1992;136:1321-6.
39. Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 1995; 6:519-24.